1.Foxman B.(2014) Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin. North Am. 28, 1-13,10.1016/j.idc.2013.09.003
2.Flores-Mireles et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015 13,269-284
3.Johnson CC. Definitions, classification, and clinical presentation of urinary tract infections. Med Clin North AM. 1991;75:241-52
4.Stamm WE, Nortrby SR. Urinary tract Infections: Disease panorama and challenges. J Infect Dis. 2001;183(Suppl 1) :1S-4S
5.林詩淳 老年人常見之秘尿道感染;志為護理。慈濟護理雜誌2010;9(5):66-70
6.莊宗憲 與導尿管相關之泌尿道感染。基層醫療 2012; 27(1):p15-20
7.Krzysztof et al. Urinary tract infection in women. Prz Menopauzalny. 2021 Apr;20(1):40-47
8.林芸合 糖尿病與泌尿道感染新進展。內科學誌 2012; 23:p173-182
9.Mihankhah et al.: Prevalence and antibiotic resistance pattern of bacteria isolated from urinary tract infections in Northern Iran. J Res Med Sci. 2017; 22: 108.
10.World Health Organization (2020) Retrieved from (May 15, 2023)
11.Langdon A, Crook N, Dantas G: The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med. 2016; 8: 39.
12.Deutsche Gesellschaft für Urologie e. V. (DGU): Epidemiologie,Diagnostik, Therapie, Prävention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. 2017.
13.Hung et al. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol Microbiol. 2002; May;44(4):903-15.
14. Gabrielle et al. Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews. Published: 17 April 2023.
15.Jesus Salinas-Casado et al. Efficacy and safety of D-mannose (2 g), 24h prolonged release, associated with Proanthocyanidin (PAC), versus isolate PAC, in the management of a series of women with recurrent urinary infections. Arch Esp Urol. 2018;71(2):169-177.
16. Panchev et al. A multicenter comparative observation on the effectiveness and the rapidness of the effect of Cystostop Rapid versus antibiotic therapy in patients with uncomplicated cystitis. Akush Ginekol(Sofiia). 2012;51(7):49-55.
17. Kranjčec B, Papeš D, Altarac S: D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014 Feb;32(1):79-84.
18. Porru D,Parmigiani A,Tinelli C,et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. J Clin Urol. 2014; 7:208-213.
19. European Medicines Agency. (2015) Retrieved from (May 15, 2023)

20. Scaglione F et al. (2021) Considerations on D-mannose Mechanism of Action and Consequent Classification of Marketed Healthcare Products. Front Pharmacol. 12: 636377.